Search
for

    Research 10 of 261

    1. Pilot study: genetic distribution of AR, FGF5, SULT1A1 and CYP3A5 polymorphisms in male Mexican population with androgenetic alopecia. PubMed · 2022
    2. Cloning of a Functional Vitamin D Receptor from the Lamprey (Petromyzon marinus), an Ancient Vertebrate Lacking a Calcified Skeleton and Teeth Endocrinology · 2003 · 104 citations
    3. Pharmacogenomic variation and chemotherapy-related toxicity profiles in pediatric patients with cancer in Tanzania: a cross-sectional study Frontiers in Pharmacology · 2026
    4. Arecaceae Elsevier eBooks · 2015
    5. A Simple Decision Tree Suited for Identification of Early Oral Drug Candidates With Likely Pharmacokinetic Nonlinearity by Intestinal CYP3A Saturation Journal of Pharmaceutical Sciences · 2020
    6. Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies Frontiers in Pharmacology · 2026
    7. Drug safety evaluation of exemestane Expert Opinion on Drug Safety · 2011 · 7 citations
    8. A population pharmacokinetic model for individualized regimens of finasteride according to CYP3A5 genotype and liver function Journal of pharmaceutical investigation · 2023
    9. SAT340 Matters Of The HAART - Ritonavir Induced CYP3A4 Inhibition of Intranasal Fluticasone Leading To Cushing’s Syndrome Journal of the Endocrine Society · 2023 · 1 citations
    10. Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases Oncotarget · 2016 · 24 citations
    All research results →

    Learn 1

    1. Dutasteride 5-alpha reductase inhibitor that blocks both enzyme types, a stronger DHT blocker than finasteride

    Community

    — no results

    Try a deeper search in community →